Congratulation to Drs. Michael Okun and Kelly Foote, on the publication of “Real-world Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control: USA Experience,” which appears in the April edition of Neurology. Abstract Objective: Here, we present preliminary outcomes from an ongoing prospective, multicenter outcomes registry conducted at…
Congratulations to Drs. Alfonso Enrique Martinez-Nunez, Joshua K. Wong, Justin D. Hilliard, Kelly D. Foote and Michael S. Okun on the publication of a Deep Brain Stimulation Case Files “Preventing Shift from Pneumocephalus During Deep Brain Stimulation Surgery: Don’t Give Up the ‘Fork in the Brain’,” which appears in Tremor…
Congratulations to Dr. Srinavasa Subramaniam on the publication of “SUMO modifies GβL and mediates mTOR signaling,” which appears in the April edition of the Journal of Biological Chemistry. Introduction The mechanistic target of rapamycin (mTOR) signaling is influenced by multiple regulatory proteins and post-translational modifications; however, underlying mechanisms remain…
Michael Okun, medical director of the Parkinson’s Foundation, told AFP that from a practical standpoint, the differences in patient outcomes were not clinically significant, but “statistically and compared to other studies, this type of difference should draw our interest and attention.” “Experts will likely argue whether this study meets a…
Duchenne muscular dystrophy families, advocates and health care providers celebrated a milestone in March with the U.S. Food and Drug Administration’s approval of the first nonsteroidal drug for the treatment of Duchenne. In findings published in the April issue of The Lancet Neurology, a team of investigators led by pharmaceutical company Italfarmaco,…
Congratulations to Dr. Kenneth Heilman on the publication of his new book “Changes in Medicine: The Way Forward,” which was published in February of 2024. The book presents the professional and personal history and milestones of renowned neurologist, Dr. Heilman, offers a unique perspective on neurology and medicine and discusses…
Millions of people worldwide are living with Parkinson’s disease. Yet, despite its prevalence, there’s a lot of confusion and misunderstanding surrounding it. In this installment of Keeping the Well in Well-thy, Barbara Archer, and renowned neurologist Dr. Michael Okun, discuss the intricacies of Parkinson’s disease. They explore the wide range…
Congratulations to Dr. Michael Okun on the publication of “Hospitalization and Parkinson’s disease: safety, quality and outcomes,” which appears as an editorial in the April 4, 2024 edition of Frontiers . Introduction For people with Parkinson’s (PWP), hospital admissions can be perilous. Nearly 300,000 PWP are admitted to the hospital…
The data is not yet there to proceed to prescribing,” Michael S. Okun, MD, national medical advisor for the Parkinson’s Foundation, told NeurologyLive®. “More importantly, the weight loss associated with GLP-1’s is not desirable in the majority of cases of Parkinson disease and the nausea and vomiting will not be a welcome…
Congratulations to Drs. Giridhar Kalamangalam, R.E. Ramsay and Michael Okun on their recently published article about the life and career of Buna Joe “BJ” Wilder, MD. in the March issue of Neurology. Excerpt “Buna Joe Wilder, MD, was an American neurologist, scientist, and philanthropist. The scientific and clinical work he…
